Microbiome Times Magazine https://validator.w3.org/feed/docs/rss2.html Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence Danone further invests in next-generation biotics with acquisition of The Akkermansia Company Home Whitepaper: Oral Drug Delivery of Live Biotherapeutics: From Development to Clinical Trial with EUDRACAP® Select Women’s Health Innovation Is Not Failing – The System Around It Is The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis How Oral Drugs and Nutrition impacts Microbiome: Realistic Dynamic In Vitro Microbiome Modeling ‘GABA Factory’ Probiotic LP815® Improves Sleep and Reduces Stress EnteroBiotix announces positive Phase 2 results for potential first-in-class, oral, full-spectrum microbiome therapy for IBS Cmbio: Advancing Microbiome Innovation Through Digital Biology Missing microbes in UK infant gut and probiotics highlighted by global microbiome atlas Immunity as a Lifestyle Priority AOB Pharma receives EMA positive decision on the Pediatric Investigation Plan for development of B244 Traces of bacteria inside brain tumors may affect tumor behavior UC San Diego researchers develop new tool to predict how bacteria influence health Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study Concerto Biosciences Announces Positive Topline Results from Phase 1b Clinical Trial of ENS-002 in Patients with Atopic Dermatitis New collaborations emerge at Gut-Immune-Brain Axis (GIBA) Network+ launch event Ferring Presents New Data Analyses for REBYOTA® Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Seres Therapeutics Receives Award of up to $3.6M from Carb-X to Develop Liquid Formulation of Ser-155 Scientists develop a way to track donor bacteria after fecal microbiota transplants Qiagen unveils new high-throughput benchtop automation system Microbiome Times Partnering Forum EU Study finds significant health benefits in adolescents with obesity treated with FMT resbiotic® Raises $14.5M to Accelerate Growth of Science-Backed Gut-X Axis Health Platform EUDRACAP® Colon: Enabling Targeted Drug Delivery to the Ileo-Colonic Region New strains of beneficial gut bacteria discovered in animals Multi-omic data from study of the longest-lived person ever recorded sheds light on biology of ageing Connection among gut fungi, genetics and disease risk in humans identified Opella announces strategic partnership with Verb Biotics for development of next-generation probiotic strain Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies CRISPR study reveals surprising role of Cas9 as a guardian of bacterial defence EXPERT’Biome, CDMO By Lallemand, Acquires Bacthera Equipment Bausch Health Partners with YUN Targeting the ileo-colonic region: Innovative solutions for sensitive APIs $2.6M NIH grant to fund new microbiome sciences training program at Penn State SNIPR BIOME Raises EUR 35 Million Series B Financing Experts publish first global framework for quantifying postbiotics MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline New study explores effects of fungicide use on corn health and microbiome Global scientific paper establishes first consensus definition of gut health New UK research network to unlock gut, immune and brain health links BioGaia launches subsidiary company dedicated to advancing microbiome research and innovation MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® Novonesis and Novo Nordisk will explore new solutions to improve metabolic health Towards a diagnostic test: the gut microbiome as a clinical target for screening for colorectal cancer Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome Phagos Raises €25m Series A